Terrell Herring serves as president of Alamo Pharma Services, a subsidiary company of Mission Pharmacal. At the latter firm, he additionally assists in directing strategic decision-making as commercial operations president. Terrell Herring and Alamo Pharma recently announced the company’s participation in a major Washington, DC conference designed to better acquaint attendees with how government regulatory processes affect innovations in the pharmaceutical industry. Alamo Pharma served as a sponsor of the FDA/CMS Summit, held toward the close of 2017. In addition, the company’s chief operating officer Peter Marchesini spoke as a member of a panel discussing the future of product-related communications, with specific reference to off-label developments. Mr. Marchesini’s panel group was moderated by journalist M. Nielsen Hobbs, whose decades of experience have informed his coverage of the pharmaceutical industry. The panel discussed the ongoing needs for training of company representatives in product knowledge and compliance requirements, and for overall fairness in labeling. KNect365, part of the Informa family of companies, hosted the summit, which also provided corporate leaders the opportunity to connect directly with regulators on issues involving formulary protocols.
0 Comments
Leave a Reply. |
AuthorTerrell Herring began working at Mission Pharmacal Company in 2010, bringing more than 25 years of experience in the pharmaceutical industry to his role as President of Commercial Operations. Archives
February 2018
Categories
All
|